Howard L Weiner Selected Research

Howard L Weiner Research Topics

Disease

77	Multiple Sclerosis 04/2024 - 01/2002
36	Tuberous Sclerosis (Bourneville's Disease) 08/2023 - 05/2003
29	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 02/2002
27	Inflammation (Inflammations) 04/2024 - 09/2002
23	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 12/2002
23	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2002
22	Epilepsy (Aura) 01/2024 - 01/2004
17	Neoplasms (Cancer) 11/2021 - 04/2002
15	Seizures (Absence Seizure) 01/2023 - 01/2004
13	Drug Resistant Epilepsy 08/2023 - 01/2004
11	Infections 04/2024 - 06/2005
10	Relapsing-Remitting Multiple Sclerosis 07/2022 - 05/2007
8	Atrophy 06/2023 - 10/2014
7	Disease Progression 11/2022 - 04/2008
7	Stroke (Strokes) 01/2022 - 12/2003
7	Arthritis (Polyarthritis) 01/2022 - 09/2002
7	Astrocytoma (Pilocytic Astrocytoma) 07/2014 - 05/2003
6	Neuroinflammatory Diseases 01/2023 - 09/2009
6	Autoimmune Diseases of the Nervous System 01/2022 - 08/2005
5	COVID-19 01/2023 - 10/2020
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 06/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 12/2002
5	Hypersensitivity (Allergy) 01/2022 - 08/2005
5	Atherosclerosis 01/2022 - 09/2002
5	Asthma (Bronchial Asthma) 01/2022 - 01/2002
5	Rheumatoid Arthritis 12/2020 - 08/2005
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 06/2006
5	Colitis 10/2016 - 12/2002
4	Uveitis 01/2022 - 08/2005
4	Infarction (Infarctions) 11/2018 - 12/2003
3	Cognitive Dysfunction 07/2023 - 02/2012
3	Pneumonia (Pneumonitis) 01/2023 - 01/2021
3	Thyroiditis 01/2022 - 08/2005
3	Chronic Progressive Multiple Sclerosis 02/2021 - 01/2004
3	Hydrocephalus (Hydrocephaly) 03/2020 - 01/2014
3	Hamartoma 01/2018 - 07/2008
3	Neurologic Manifestations (Neurological Manifestations) 01/2018 - 04/2014
3	Glomerulonephritis 01/2018 - 05/2003
3	Demyelinating Diseases (Demyelinating Disease) 12/2014 - 07/2007
3	Meningoencephalitis 09/2009 - 03/2006
2	Focal Cortical Dysplasia 01/2021 - 12/2018
2	Brain Neoplasms (Brain Tumor) 03/2020 - 07/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 05/2017
2	Gliosis 12/2018 - 01/2008

Drug/Important Bio-Agent (IBA)

35	trans-sodium crocetinate (crocetin)IBA 08/2023 - 01/2004
21	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2008
16	Monoclonal AntibodiesIBA 12/2023 - 06/2006
13	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2002
13	MicroRNAs (MicroRNA)IBA 06/2023 - 07/2012
12	Interleukin-10 (Interleukin 10)IBA 11/2017 - 09/2002
10	AntigensIBA 01/2022 - 02/2002
10	Peptides (Polypeptides)IBA 11/2021 - 03/2003
9	InterferonsIBA 01/2020 - 08/2004
9	Glatiramer Acetate (Copaxone)FDA Link 11/2018 - 02/2002
8	Amyloid beta-PeptidesIBA 05/2024 - 08/2003
7	Transforming Growth Factor beta (TGF-beta)IBA 03/2009 - 03/2003
6	LigandsIBA 07/2023 - 04/2002
6	AutoantigensIBA 10/2016 - 09/2002
6	Myelin-Oligodendrocyte GlycoproteinIBA 04/2008 - 05/2003
5	Amyloid (Amyloid Fibrils)IBA 05/2024 - 03/2006
5	Glial Fibrillary Acidic ProteinIBA 04/2024 - 01/2023
5	Fingolimod Hydrochloride (FTY720)FDA Link 05/2023 - 12/2015
5	Interferon beta-1a FDA Link 07/2022 - 11/2012
5	CytokinesIBA 12/2020 - 12/2008
5	Anticonvulsants (Antiepileptic Drugs)IBA 04/2020 - 01/2004
4	Interleukin-27 (Interleukin 27)IBA 04/2023 - 08/2009
4	Interleukin-17 (Interleukin 17)IBA 01/2023 - 12/2008
4	foralumabIBA 01/2023 - 01/2021
4	Alemtuzumab (Campath)FDA Link 10/2019 - 11/2012
4	TOR Serine-Threonine KinasesIBA 01/2018 - 12/2013
4	Natalizumab (Tysabri)FDA Link 05/2017 - 05/2007
4	ChemokinesIBA 03/2008 - 05/2002
3	N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyanilineIBA 04/2024 - 09/2018
3	GadoliniumIBA 01/2019 - 08/2004
3	Interferon-betaIBA 11/2018 - 05/2002
3	AutoantibodiesIBA 01/2018 - 11/2008
3	Baclofen FDA LinkGeneric 01/2017 - 06/2005
3	AntibodiesIBA 04/2016 - 03/2010
3	GlycolipidsIBA 10/2014 - 01/2013
3	OsteopontinIBA 04/2014 - 12/2008
3	Messenger RNA (mRNA)IBA 09/2010 - 05/2005
3	Myelin Basic ProteinIBA 03/2006 - 02/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 05/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 10/2022
2	RNA (Ribonucleic Acid)IBA 11/2021 - 09/2012
2	Muromonab-CD3 (Muromonab CD3)FDA Link 07/2019 - 01/2017
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019 - 11/2010
2	Retinaldehyde (Retinal)IBA 01/2018 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2017 - 09/2010

Therapy/Procedure

42	Therapeutics 10/2023 - 01/2002
11	Immunotherapy 12/2023 - 05/2006
8	Electrodes (Electrode) 02/2014 - 02/2005
7	Oral Administration 11/2019 - 12/2003
6	Intranasal Administration 12/2023 - 07/2009
6	Transplantation 03/2016 - 06/2006
5	Vagus Nerve Stimulation 12/2023 - 11/2009
2	Craniotomy 04/2024 - 01/2009
2	Lasers (Laser) 01/2024 - 01/2023
2	Aftercare (After-Treatment) 11/2023 - 01/2013
2	Catheters 08/2023 - 03/2011